Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Vinconate

From Wikipedia, the free encyclopedia
(Redirected from C18H20N2O2)
Vinconate
Clinical data
ATC code
  • none
Identifiers
  • methyl (3aS)-3-ethyl-2,3,3a,4-tetrahydro-1H-indolo[3,2,1-"de]-1,5-maphthyridine-6-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.067.969 Edit this at Wikidata
Chemical and physical data
FormulaC18H20N2O2
Molar mass296.370 g·mol−1
3D model (JSmol)
  • O=C(OC)C/1=C/CC3c2n\1c4ccccc4c2CCN3CC
  • InChI=1S/C18H20N2O2/c1-3-19-11-10-13-12-6-4-5-7-14(12)20-16(18(21)22-2)9-8-15(19)17(13)20/h4-7,9,15H,3,8,10-11H2,1-2H3 checkY
  • Key:JWOSSISWAJNJIA-UHFFFAOYSA-N checkY
 X markNcheckY (what is this?)  (verify)

Vinconate is a synthetic vincamine analog used as a nootropic.[1]

Vinconate, even when systemically administered, enhances the endogenous release of dopamine in the striatum, probably via the stimulation of presynaptic muscarinic receptors.[2]

Synthesis

[edit]
Synthesis:[3] Patent:[4]

References

[edit]
  1. Brimble MA, Levi MS (2010). "A Review of Neuroprotective Agents". In Atta-ur-Rahman, Reitz AB (eds.). Frontiers in Medicinal Chemistry. Vol. 3. SAIF Zone: Bentham Science Publishers. p. 182. ISBN 978-1-60805-206-6.
  2. Iino T, Katsura M, Kuriyama K. Effect of vinconate on the extracellular levels of dopamine and its metabolites in the rat striatum: microdialysis studies. Eur J Pharmacol. 1995 Nov 3;286(1):99-103. doi: 10.1016/0014-2999(95)00545-v. PMID: 8566157.
  3. Castaer, J.; Serradell, MN; Vinconate. Drugs Fut 1984, 9, 4, 283.
  4. Jean A. A. J. Hannart, U.S. patent 4,200,638 (1980 to Omnium Chimique SA).